A randomized, double-blind, comparative, phase III, non-inferiority clinical trial between triamcinolone acetonide nasal spray (TAA) and fluticasone propionate nasal spray (FP) in adults suffering from perennial allergic
randomized, double-blind, parallel-group, multicenter, phase III, prospective, non-inferiority clinical trial (NCT 03317015) sponsored by Sanofi compared triamcinolone acetonide (TAA) nasal spray (220 μg/d) with…

